Objective: the aim is to determine immunopathological modifications in rectal mucosa from rabbits after local challenge in ovalbumin (OVA) sensitized animals previously treated with montelukast. Material and methods: experimental design: thirty two rabbits divided into four groups: G1: normal; G2: subcutaneously OVA sensitized; G3: sensitized, locally OVA challenged and sampled 4 hours after challenge; and G4: sensitized, locally OVA challenged and treated 4 hours before challenge with montelukast (0.15 mg/kg). Specific anti-OVA IgE levels were evaluated by passive cutaneous anaphylaxis test (PCA). In each group 200 high microscopical power fields (HPF) were counted. Results were expressed as arithmetic mean and SE. Anti -CD4, CD5, µ chain monoclonal antibodies were used. Avidin biotin horseradish peroxidase system was used. Results: CD 4: G1: 8.3 ± 0.06; G2: 13.4 ± 0.08, G3: 8.25 ± 0.06, G4: 11.8 ± 0.02. CD 5: G1: 7.3 ± 0.05; G2: 9.4 ± 0.05, G3: 11.3 ± 0.06, G4: 8.1 ± 0.06. μ chain: G1: 10.4 ± 0.06; G2: 3.8 ± 0.02, G3: 6.0 ± 0.10, G4: 2.2 ± 0.10. In all cases, experimental groups (G3 vs. G4) presented statistical significant differences (p < 0.05). CD4+, CD5+ cells and μ chain+ decrease in experimental group (G4), probably due to lymphocyte migration inhibition to challenged mucosa. μ chain+ cell decrease could be based on B cell activation and expression of different surface immunoglobulins. Cells expressing μ chain decreased in G2 and G3 likely due to activation of B cells and subsequent expression of other immunoglobulin chains in cell surface. Conclusions: we conclude that obtained data are important to elucidate immunopathology of local anaphylactic reaction in rectal mucosa from systemic sensitized animals after treatment with montelukast.

Aim: the aim is to determine immunopathological modifications in rectal mucosa from rabbit after local challenge in sensitized animals with ovalbumin (OVA). Experimental design: thirty rabbits divided into three groups: G1: normal, G2: subcutaneously OVA sensitized, G3: sensitized, locally OVA challenged and sampled 4 hours after challenge. Specific anti-OVA IgE levels were evaluated by passive cutaneous anaphylaxis test (PCA). In each group 200 high microscopical power fields (HPF) were counted. Results were expressed as arithmetic mean and SE. Statistical analysis was made using Student t test. Anti-CD4, CD5, µ chain, CD25 and RLA II monoclonal antibodies were used. Avidin biotin horseradish peroxidase system was used. Results: CD 4: G1: 8,3 ± 0,06; G2: 13,4 ± 0,08 and G3: 8,25 ± 0,06. CD 5: G1: 7,3 ± 0,05; G2: 9,4 ± 0,05 and G3: 11,3 ± 0,06. CD 25: G1: 13 ± 0,08; G2: 15,1 ± 0,13 and G3: 25,5 ± 0,15. m chain: G1: 10,4 ± 0,06; G2: 3,8 ± 0,02 and G3: 6,0 ± 0,10. RLA II (DR): G1: 11,6 ± 0,O5; G2: 19,2 ± 0,09 and G3: 19,1 ± 0,11. In all cases, experimental groups (G2 and G3) presented statistical significant differences vs. control group (G1) (p < 0.001). Conclusions: interleukin-2 receptor (CD25+ cells) increase in experimental groups. Cells expressing µ chain decreased in G2 and G3 likely due to activation of B cells and subsequent expression of other immunoglobulin chains in cell surface. RLA II expression is higher in G2 and G3. This receptor is considered an activation marker expressed by macrophages, T and B cells. We conclude that obtained data are important to elucidate immunopathology of local anaphylactic reaction in rectal mucosa from systemic sensitized animals.

Objetivo: determinar las modificaciones inmunopatológicas en la mucosa rectal de conejo sensibilizado con ovoalbúmina (OVA) y desafiado localmente. Diseño experimental: treinta conejos divididos en tres grupos G1: normal; G2 sensibilizado por vía subcutánea con OVA y G3: sensibilizado y desafiado localmente con OVA y muestreados 4 horas después del desafío. Los niveles de IgE anti-OVA específica fueron evaluados por el test de anafilaxia cutánea pasiva (PCA). Se contaron 200 campos de mayor aumento en cada grupo. Los resultados fueron expresados como media aritmética y error standard aplicándose el test de la t de Student. Resultados: CD 4: G1: 8,3 ± 0,06; G2: 13,4 ± 0,08 y G3: 8,25 ± 0,06. CD 5: G1: 7,3 ± 0,05; G2: 9,4 ± 0,05 y G3: 11,3 ± 0,06. CD 25: G1: 13., ± 0,08; G2: 15,1 ± 0,13 y G3: 25,5 ± 0,15. Cadena µ: G1: 10,4 ± 0,06; G2: 3,8 ± 0,02 y G3: 6,0 ± 0,10. RLA II (DR): G1: 11,6 ± 0,O5; G2: 19,2 ± 0,09 y G3: 19,1 ± 0,11. En todos los casos los grupos G2 y G3 presentaron diferencias estadísticamente significativas versus G1 (p < 0,001). Conclusión: observamos un incremento en el número de células CD25+ (receptor interleuquina-2) en G3 y una disminución en células cadena µ positivas en G2 y G3, probablemente debido a la activación de células B y expresión de otras inmunoglobulinas en superficie celular. La expresión de RLA II fue mayor en G2 y G3. Este receptor es considerado un marcador de activación expresado por macrófagos, células T y B. Concluimos que los datos obtenidos constituyen un aporte al conocimiento de la inmunopatología de la reacción anafiláctica local en mucosa rectal en animales sensibilizados por vía sistémica.

Pelo estudo das alterações morfológicas nos nódulos hemolinfóides, averiguou-se a compensação da deficiência imunológica transitória em bovinos esplenectomizados. Houve aumento acentuado de tamanho dos nódulos hemolinfóides dois meses após a esplenectomia. Além disso, ocorreu aumento significativo na espessura da zona intermediária dos nódulos hemolinfóides, bem como hiperplasia celular porém sem modificação na população e distribuição das células. As células B foram detectadas na zona central dos folículos, enquanto que as CD4+ se assentaram no córtex, na área interfolicular e nos cordões da zona intermediária. As células M2+ estavam dispersas no tecido cordonal e as CD8+ coraram-se de modo similar às células CD4+.